15q26 deletion in a patient with congenital heart defect, growth restriction and intellectual disability: case report and literature review.
15q26 deletion
Array-CGH
CHD
Case report
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
16 Sep 2021
16 Sep 2021
Historique:
received:
12
06
2020
accepted:
07
07
2021
entrez:
17
9
2021
pubmed:
18
9
2021
medline:
30
12
2021
Statut:
epublish
Résumé
15q26 deletion is a relatively rare chromosomal disorder, and it is described only in few cases. Patients with this aberration show many signs and symptoms, particularly pre- and postnatal growth restriction, developmental delay, microcephaly, intellectual disability and various congenital malformations. We report on a girl, 4 years old, of consanguineous parents, with a 15q26 deletion. Clinical manifestations included failure to thrive, developmental delay, microcephaly, dysmorphic facies with broad forehead, hypertelorism, narrowed eyelid slits and protruding columella. The patient also showed skeletal abnormalities, especially clinodactyly of the 5th finger, varus equine right foot and left club foot. Additionally, she had teething delay and divergent strabismus. Heart ultrasound displayed two atrial septal defects with left-to-right shunt, enlarging the right cavities. Routine cytogenetic analysis revealed a shortened 15q chromosome. Subsequent array analysis disclosed a terminal 9.15 Mb deletion at subband 15q26.1-q26.3. Four candidate genes associated with 15q26 deletion phenotype were within the deleted region, i.e. IGF1R, NR2F2, CHD2 and MEF2A. We report on an additional case of 15q26 monosomy, characterized by array-CGH. Molecular cytogenetic analysis allowed us to identify the exact size of the deletion, and four candidate genes for genotype-phenotype correlation. 15q26 monosomy should be considered when growth retardation is associated with hearing anomalies and congenital heart defect, especially atrioventricular septal defects (AVSDs) and/or aortic arch anomaly (AAA).
Sections du résumé
BACKGROUND
BACKGROUND
15q26 deletion is a relatively rare chromosomal disorder, and it is described only in few cases. Patients with this aberration show many signs and symptoms, particularly pre- and postnatal growth restriction, developmental delay, microcephaly, intellectual disability and various congenital malformations.
CASE PRESENTATION
METHODS
We report on a girl, 4 years old, of consanguineous parents, with a 15q26 deletion. Clinical manifestations included failure to thrive, developmental delay, microcephaly, dysmorphic facies with broad forehead, hypertelorism, narrowed eyelid slits and protruding columella. The patient also showed skeletal abnormalities, especially clinodactyly of the 5th finger, varus equine right foot and left club foot. Additionally, she had teething delay and divergent strabismus. Heart ultrasound displayed two atrial septal defects with left-to-right shunt, enlarging the right cavities. Routine cytogenetic analysis revealed a shortened 15q chromosome. Subsequent array analysis disclosed a terminal 9.15 Mb deletion at subband 15q26.1-q26.3. Four candidate genes associated with 15q26 deletion phenotype were within the deleted region, i.e. IGF1R, NR2F2, CHD2 and MEF2A.
CONCLUSION
CONCLUSIONS
We report on an additional case of 15q26 monosomy, characterized by array-CGH. Molecular cytogenetic analysis allowed us to identify the exact size of the deletion, and four candidate genes for genotype-phenotype correlation. 15q26 monosomy should be considered when growth retardation is associated with hearing anomalies and congenital heart defect, especially atrioventricular septal defects (AVSDs) and/or aortic arch anomaly (AAA).
Identifiants
pubmed: 34530895
doi: 10.1186/s13052-021-01121-5
pii: 10.1186/s13052-021-01121-5
pmc: PMC8447573
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
188Informations de copyright
© 2021. The Author(s).
Références
J Clin Endocrinol Metab. 2011 Jan;96(1):E130-4
pubmed: 20962017
Prenat Diagn. 2006 Jun;26(6):577-80
pubmed: 16700088
Eur J Med Genet. 2012 Feb;55(2):132-4
pubmed: 22178256
Mol Cell Endocrinol. 2020 Dec 1;518:111035
pubmed: 32941924
N Engl J Med. 2003 Dec 4;349(23):2211-22
pubmed: 14657428
Hum Mol Genet. 2004 Dec 15;13(24):3181-8
pubmed: 15496429
J Med Genet. 2001 Sep;38(9):617-21
pubmed: 11565548
Am J Med Genet A. 2008 Jul 1;146A(13):1761-4
pubmed: 18512227
Horm Res Paediatr. 2015 Apr 22;:
pubmed: 25924833
Am J Hum Genet. 2005 May;76(5):877-82
pubmed: 15750894
Am J Med Genet A. 2004 Apr 15;126A(2):183-5
pubmed: 15057983
Eur J Med Genet. 2007 Nov-Dec;50(6):432-40
pubmed: 17931990
J Neurodev Disord. 2014;6(1):9
pubmed: 24834135
Cell. 1993 Oct 8;75(1):73-82
pubmed: 8402902
Eur J Pediatr. 2017 Jan;176(1):137-142
pubmed: 27826649
Clin Genet. 2008 Nov;74(5):455-62
pubmed: 18651844
Eur J Med Genet. 2011 May-Jun;54(3):354-6
pubmed: 21172461
J Perinatol. 2005 Jun;25(6):429-32
pubmed: 15843813
Endocr J. 2011;58(3):155-9
pubmed: 21242650
Eur J Med Genet. 2013 Jul;56(7):346-50
pubmed: 23603061
Fetal Diagn Ther. 2004 Nov-Dec;19(6):510-2
pubmed: 15539876
Am J Med Genet A. 2004 Nov 1;130A(4):340-4
pubmed: 15384084
Front Mol Neurosci. 2018 Jun 15;11:208
pubmed: 29962935
Eur J Med Genet. 2014 Sep;57(9):520-3
pubmed: 24932903
Am J Hum Genet. 2014 Apr 3;94(4):574-85
pubmed: 24702954
J Med Genet. 2010 Jul;47(7):492-8
pubmed: 19955558
Science. 2003 Nov 28;302(5650):1578-81
pubmed: 14645853
Nat Genet. 2013 Jul;45(7):825-30
pubmed: 23708187
Am J Med Genet. 1991 Jan;38(1):74-9
pubmed: 1849352
Clin Case Rep. 2018 Feb 14;6(4):612-616
pubmed: 29636925
Nat Commun. 2019 Oct 8;10(1):4567
pubmed: 31594955
Annu Rev Cell Dev Biol. 1998;14:167-96
pubmed: 9891782
J Clin Endocrinol Metab. 2003 Dec;88(12):5981-8
pubmed: 14671200
Lancet. 2012 Nov 10;380(9854):1674-82
pubmed: 23020937
Eur J Hum Genet. 2006 Sep;14(9):999-1008
pubmed: 16736036
Am J Med Genet A. 2008 May 1;146A(9):1117-27
pubmed: 18386809
BMC Med Genet. 2008 Jan 14;9:2
pubmed: 18194513